{"id":"d064-and-d702-qd","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3400969","moleculeType":"Small molecule","molecularWeight":"413.48"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Without access to detailed pharmacological data on D064 and D702 individually, the exact mechanism of this combination cannot be reliably described. The 'QD' (once daily) dosing suggests oral small-molecule agents. Chong Kun Dang Pharmaceutical's pipeline includes metabolic and inflammatory disease programs, but the precise targets and mechanism for this Phase 3 combination remain proprietary.","oneSentence":"D064 and D702 are a fixed-dose combination targeting dual pathways in metabolic or inflammatory disease, though the specific molecular targets are not publicly disclosed.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:08:26.941Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06121518","phase":"PHASE3","title":"Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2023-07-31","conditions":"Essential Hypertension","enrollment":235},{"nctId":"NCT05881707","phase":"PHASE1","title":"A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg","status":"COMPLETED","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2023-07-04","conditions":"Hypertension","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["D064 and D702 Combination Therapy"],"phase":"phase_3","status":"active","brandName":"D064 and D702, QD","genericName":"D064 and D702, QD","companyName":"Chong Kun Dang Pharmaceutical","companyId":"chong-kun-dang-pharmaceutical","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}